All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • EVO301Phase 21 trial

    Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis

  • EVX-01Phase 21 trial

    Evaxion Biotech A/S · Melanoma Stage IV, Unresectable Melanoma

  • EX039Phase 21 trial

    Excelsior · Alzheimer Disease

  • EX103Phase 21 trial

    Guangzhou Excelmab Inc. · CD20-positive Non-Hodgkin Lymphoma

  • EXE-346Phase 21 trial

    Exegi Pharma, LLC · Ileal Pouch

  • EXG110Phase 21 trial

    Guangzhou Jiayin Biotech Ltd · Fabry Disease

  • EXG202Phase 21 trial

    Guangzhou Jiayin Biotech Ltd · Wet Age-related Macular Degeneration

  • exidavnemabPhase 21 trial

    BioArctic AB · Parkinson Disease, Multiple System Atrophy

  • EXPD-101FXS7553Phase 21 trial

    Expedition Therapeutics, Inc · Chronic Obstructive Pulmonary Disease (COPD)

  • EXT608Phase 21 trial

    Extend Biosciences Inc. · Hypoparathyroidism

  • Extended PhasePhase 21 trial

    Chengdu Zenitar Biomedical Technology Co., Ltd · Polycythemia Vera (PV)

  • EYU688Phase 21 trial

    Novartis · Dengue

  • F182112Phase 21 trial

    Shandong New Time Pharmaceutical Co., LTD · Relapsed or Refractory Multiple Myeloma

  • F573Phase 21 trial

    Beijing Continent Pharmaceutical Co, Ltd. · Acute Liver Failure, Acute-On-Chronic Liver Failure

  • FamitinibSHR-1020Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Recurrent or Metastatic Cervical Cancer

  • famzeretcelhuman retinal progenitor cells, jCellPhase 21 trial

    jCyte, Inc · Retinitis Pigmentosa

  • Farletuzumab ecteribulinMORAb-202Phase 21 trial

    Eisai · Solid Tumor

  • FB-1603Phase 21 trial

    Febico Biomedical Corp. · Hepatocellular Carcinoma

  • FB102Phase 21 trial

    Forte Biosciences, Inc. · Celiac Disease

  • FB704APhase 21 trial

    Oneness Biotech Co., Ltd. · Severe Asthma

  • FB849dose-escalation FB849, dose-expansion of FB849Phase 21 trial

    1ST Biotherapeutics, Inc. · Advanced Solid Tumor

  • FC084CSAPhase 21 trial

    FindCure Biosciences (ZhongShan) Co., Ltd. · Advanced Malignant Solid Tumors

  • FDC fianlimabPhase 21 trial

    Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)

  • FF-10832Gemcitabine LiposomePhase 21 trial

    Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer

  • FG-3246FOR46Phase 21 trial

    Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer

  • FG001Optical imaging agent FG001, Fluorescent imaging agent FG001Phase 21 trial

    FluoGuide A/S · High-Grade Glioma (WHO III-IV)

  • FHND1002Phase 21 trial

    Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)

  • FID007Paclitaxel in Polyethyloxazoline Polymer, Nanoencapsulated Paclitaxel FID-007Phase 21 trial

    Fulgent Pharma LLC. · Head and Neck Squamous Cell Carcinoma

  • FinotonlimabPhase 21 trial

    Sichuan Baili Pharmaceutical Co., Ltd. · Advanced Hepatocellular Carcinoma

  • Fixed cemiplimabPhase 21 trial

    Regeneron · Melanoma

  • FluvustatPhase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer

  • FluzoparibPhase 21 trial

    Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors

  • FLX475tivumecirnonPhase 21 trial

    RAPT Therapeutics, Inc., a member of the GSK plc group of companies · Advanced Cancer

  • FMC-242Phase 21 trial

    Frontier Medicines Corporation · Locally Advanced Solid Tumor

  • FNP-223Phase 21 trial

    Ferrer Internacional S.A. · Progressive Supranuclear Palsy

  • FOG-001Phase 21 trial

    Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor

  • ForalumabPhase 21 trial

    Tiziana Life Sciences LTD · Secondary Progressive Multiple Sclerosis

  • FrevecitinibPhase 21 trial

    Kinaset Therapeutics Inc · Severe Asthma

  • FT819Phase 21 trial

    Fate Therapeutics · Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus

  • FT839Phase 21 trial

    Fate Therapeutics · ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA)

  • FWY003Phase 21 trial

    Novartis · Geographic Atrophy Secondary to Age-related Macular Degeneration

  • FXR0906Phase 21 trial

    Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd. · sHTG, HTG With ASCVD (Diagnosed or at Increased Risk)

  • FXS5626Phase 21 trial

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Active Non-anterior, Non-infectious Uveitis

  • Ga-68-NGULPhase 21 trial

    Cellbion Co., Ltd. · Prostate Cancer, mCRPC

  • GAd-209-FSPPhase 21 trial

    Nouscom SRL · Solid Tumor, Adult

  • GAd20-209-FSPPhase 21 trial

    Nouscom SRL · Solid Tumor, Adult

  • GAL-101Phase 21 trial

    Galimedix Therapeutics Inc · Geographic Atrophy of the Macula

  • GarutadustatISM5411Phase 21 trial

    InSilico Medicine Hong Kong Limited · Ulcerative Colitis

  • gavo-celPhase 21 trial

    TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura

  • GB2064Phase 21 trial

    Galecto Biotech AB · Myelofibrosis

NewerPage 53 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.